129.45000 EUR
0.2
0.15%
Last update Dec 16, 8:10 AM CET
Main market
Day range
129.45000
129.45000
Previous close
129.25
Open
129.45000
Access this stock data via API
Subscribe
Neurocrine Biosciences Inc.
129.45
0.20
0.15%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 2.0B 1.9B 1.5B 1.1B
Cost of revenue 29.0M 39.7M 23.2M 14.3M
Gross profit 2.0B 1.8B 1.5B 1.1B
Operating expense
Research & development 623.1M 565M 463.8M 328.1M
Selling general and admin 858.4M 887.6M 752.7M 583.3M
Other operating expenses
Operating income 496.9M 394.8M 249M 207.8M
Non operating interest income
Income 77.6M 52.8M 4.1M
Expense 107.9M 4.6M 7.1M 25.8M
Other income expense -52.3M -115.5M -39.2M -80.6M
Pretax income 414.2M 332.1M 213.9M 101.4M
Tax provision 123.3M 82.4M 59.4M 11.8M
Net income 290.9M 249.7M 154.5M 89.6M
Basic EPS 3.4 2.6 1.6 1.0
Diluted EPS 3.3 2.5 1.6 0.9
Basic average shares 85.6M 101.7M 99.7M 98.5M
Diluted average shares 85.6M 101.7M 99.7M 98.5M
EBITDA 597.5M 531.6M 303.8M 218.7M
Net income from continuing op. 290.9M 249.7M 154.5M 89.6M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 34 minutes

19:25
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).